On Thursday, the GOP-led House Judiciary Committee announced that it received bombshell evidence that suggested Pfizer executives pushed to delay full testing for their company’s COVID vaccine until after the 2020 election.
British drugmaker GSK informed the panel that Philip Dormitzer, a former Pfizer executive who became a senior scientist at GSK, told colleagues at GSK that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
The Judiciary Committee, led by Chairman Jim Jordan (R-OH), said that it had sought information from GSK after The Wall Street Journal reported in March that U.S. prosecutors were looking into a tip from the company that came in “soon” after President Donald Trump won a second term in 2024.
The Journal noted that Trump, who lost to Joe Biden in the 2020 presidential contest, “for years has claimed that Pfizer sat on the positive results of clinical trials, which could have reflected well on his management of the pandemic and reassured voters as they headed to the polls. There has never been evidence to support the accusation, and the development of the Covid vaccines is widely viewed as a medical miracle, coming faster than any other vaccine in history.”
As relayed by the Judiciary Committee, GSK responded to the panel’s inquiry in mid-April. In another part of the reply given to congressional investigators, GSK said Dormitzer had requested a transfer over concerns about what the new Trump administration might do to him.
“In November 2024, shortly after the election, Dr. Dormitzer approached a representative from the GSK human resources team to speak about a potential relocation abroad. As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine,” GSK said. “According to the human resources representative, when asked what prompted his request, Dr. Dormitzer made a comment to the effect of: ‘Let’s just say it wasn’t a coincidence, the timing of the vaccine.’”
The Journal reported in March that GSK and Pfizer, who are rivals in the pharmaceutical industry, have sued each other over patent rights tied to vaccines.
Dormitzer, who has since left GSK, provided a statement to the newspaper.
“My Pfizer colleagues and I did everything we could to get the FDA’s Emergency Use Authorization at the very first possible moment,” Dormitzer said. “Any other interpretation of my comments about the pace of the vaccine’s development would be incorrect.”
The House panel sent a letter to Dormitzer requesting documents and a transcribed interview by May 29. Pfizer Chairman and CEO Albert Bourla was the recipient of another letter that sought records by the same date.
In response to a request for comment, a Pfizer representative told The Daily Wire that the company received the letter asking about the allegations in the Wall Street Journal report and “will respond directly” to the House Judiciary Committee.
Pfizer also provided a statement that said: “The COVID-19 vaccine development process was driven by science and guided by the U.S. FDA back in 2020. We have consistently and transparently reiterated the facts and the timeline of the tireless work of scientists, regulators, and thousands of clinical trial volunteers who made the vaccine possible. Theories to the contrary are simply untrue and being manufactured.”
The Judiciary Committee emphasized that it is “unclear which Pfizer R&D employees were involved with Dr. Dormitzer in the decision to delay the clinical testing,” but did note that he “represented to GSK that Pfizer’s CEO was not aware of the delay.”
The Daily Wire has also reached out to GSK, seeking comment.
Jordan (R-OH), a close ally to Trump, posted on X in response to the information obtained by his panel: “Did Pfizer executives conspire to delay COVID-19 vaccine testing to influence the 2020 election? Based on our oversight, it sure looks like it.”
[#item_full_content]
[[{“value”:”
On Thursday, the GOP-led House Judiciary Committee announced that it received bombshell evidence that suggested Pfizer executives pushed to delay full testing for their company’s COVID vaccine until after the 2020 election.
British drugmaker GSK informed the panel that Philip Dormitzer, a former Pfizer executive who became a senior scientist at GSK, told colleagues at GSK that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
The Judiciary Committee, led by Chairman Jim Jordan (R-OH), said that it had sought information from GSK after The Wall Street Journal reported in March that U.S. prosecutors were looking into a tip from the company that came in “soon” after President Donald Trump won a second term in 2024.
The Journal noted that Trump, who lost to Joe Biden in the 2020 presidential contest, “for years has claimed that Pfizer sat on the positive results of clinical trials, which could have reflected well on his management of the pandemic and reassured voters as they headed to the polls. There has never been evidence to support the accusation, and the development of the Covid vaccines is widely viewed as a medical miracle, coming faster than any other vaccine in history.”
As relayed by the Judiciary Committee, GSK responded to the panel’s inquiry in mid-April. In another part of the reply given to congressional investigators, GSK said Dormitzer had requested a transfer over concerns about what the new Trump administration might do to him.
“In November 2024, shortly after the election, Dr. Dormitzer approached a representative from the GSK human resources team to speak about a potential relocation abroad. As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine,” GSK said. “According to the human resources representative, when asked what prompted his request, Dr. Dormitzer made a comment to the effect of: ‘Let’s just say it wasn’t a coincidence, the timing of the vaccine.’”
The Journal reported in March that GSK and Pfizer, who are rivals in the pharmaceutical industry, have sued each other over patent rights tied to vaccines.
Dormitzer, who has since left GSK, provided a statement to the newspaper.
“My Pfizer colleagues and I did everything we could to get the FDA’s Emergency Use Authorization at the very first possible moment,” Dormitzer said. “Any other interpretation of my comments about the pace of the vaccine’s development would be incorrect.”
The House panel sent a letter to Dormitzer requesting documents and a transcribed interview by May 29. Pfizer Chairman and CEO Albert Bourla was the recipient of another letter that sought records by the same date.
In response to a request for comment, a Pfizer representative told The Daily Wire that the company received the letter asking about the allegations in the Wall Street Journal report and “will respond directly” to the House Judiciary Committee.
Pfizer also provided a statement that said: “The COVID-19 vaccine development process was driven by science and guided by the U.S. FDA back in 2020. We have consistently and transparently reiterated the facts and the timeline of the tireless work of scientists, regulators, and thousands of clinical trial volunteers who made the vaccine possible. Theories to the contrary are simply untrue and being manufactured.”
The Judiciary Committee emphasized that it is “unclear which Pfizer R&D employees were involved with Dr. Dormitzer in the decision to delay the clinical testing,” but did note that he “represented to GSK that Pfizer’s CEO was not aware of the delay.”
The Daily Wire has also reached out to GSK, seeking comment.
Jordan (R-OH), a close ally to Trump, posted on X in response to the information obtained by his panel: “Did Pfizer executives conspire to delay COVID-19 vaccine testing to influence the 2020 election? Based on our oversight, it sure looks like it.”
“}]]
